Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heide L Ford

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Oncotarget|January 1, 2017
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogrammingAgnieszka A Kendrick, Johnathon Schafer, Monika Dzieciatkowska, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1Ricardo D Coletta, Kimberly Christensen, Kelly J Reichenberger, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Cancer Research|February 27, 2015
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor InitiationDavid J Drasin, Anna L Guarnieri, Deepika Neelakantan, et al.
The Journal of Biological Chemistry|May 25, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Genes & Development|November 20, 2025
Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systemsChristopher B Nelson, Jadon K Wells, Ekaagra Kesarwani, et al.
Cancer Research|January 5, 2019
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell ProgramMichael U J Oliphant, Melanie Y Vincent, Matthew D Galbraith, et al.
The Journal of Clinical Investigation|May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulationRebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Characterization of two avian MHC-like genes reveals an ancient origin of the CD1 familyMarcia M Miller, Carren Wang, Emilio Parisini, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Oncotarget|January 1, 2017
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogrammingAgnieszka A Kendrick, Johnathon Schafer, Monika Dzieciatkowska, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
An EYA3/NF-κB/CCL2 signaling axis suppresses cytotoxic NK cells in the pre-metastatic niche to promote triple negative breast cancer metastasisSheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 5, 2004
The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1Ricardo D Coletta, Kimberly Christensen, Kelly J Reichenberger, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Cancer Research|February 27, 2015
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor InitiationDavid J Drasin, Anna L Guarnieri, Deepika Neelakantan, et al.
The Journal of Biological Chemistry|May 25, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Genes & Development|November 20, 2025
Potent synthetic lethality between PLK1 and EYA family inhibitors in tumors of the central and peripheral nervous systemsChristopher B Nelson, Jadon K Wells, Ekaagra Kesarwani, et al.
Cancer Research|January 5, 2019
SIX2 Mediates Late-Stage Metastasis via Direct Regulation of <i>SOX2</i> and Induction of a Cancer Stem Cell ProgramMichael U J Oliphant, Melanie Y Vincent, Matthew D Galbraith, et al.
The Journal of Clinical Investigation|May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulationRebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 2005
Characterization of two avian MHC-like genes reveals an ancient origin of the CD1 familyMarcia M Miller, Carren Wang, Emilio Parisini, et al.
Pageof 9